1.75
前日終値:
$1.77
開ける:
$1.77
24時間の取引高:
422.71K
Relative Volume:
0.44
時価総額:
$126.24M
収益:
-
当期純損益:
$-292.19M
株価収益率:
-0.3855
EPS:
-4.54
ネットキャッシュフロー:
$-208.41M
1週間 パフォーマンス:
+3.55%
1か月 パフォーマンス:
+24.11%
6か月 パフォーマンス:
-9.33%
1年 パフォーマンス:
-45.99%
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
名前
Zentalis Pharmaceuticals Inc
セクター
電話
(858) 263-4333
住所
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
ZNTL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ZNTL
Zentalis Pharmaceuticals Inc
|
1.75 | 127.68M | 0 | -292.19M | -208.41M | -4.54 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-08-12 | アップグレード | Wedbush | Underperform → Neutral |
2024-06-20 | ダウングレード | UBS | Buy → Neutral |
2024-06-18 | ダウングレード | Jefferies | Buy → Hold |
2024-06-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-06-18 | ダウングレード | Wedbush | Neutral → Underperform |
2024-06-18 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2023-11-08 | ダウングレード | Wedbush | Outperform → Neutral |
2023-11-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
2022-07-12 | 開始されました | Cowen | Outperform |
2022-04-06 | 開始されました | Wells Fargo | Overweight |
2021-10-07 | 再開されました | Jefferies | Buy |
2021-09-30 | 開始されました | Stifel | Buy |
2021-09-29 | 開始されました | Oppenheimer | Outperform |
2021-05-21 | 開始されました | UBS | Buy |
2021-01-20 | 開始されました | Wedbush | Outperform |
2020-09-29 | 開始されました | Cantor Fitzgerald | Overweight |
2020-08-27 | 開始されました | H.C. Wainwright | Buy |
2020-04-28 | 開始されました | Guggenheim | Buy |
2020-04-28 | 開始されました | Jefferies | Buy |
2020-04-28 | 開始されました | Morgan Stanley | Overweight |
2020-04-28 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Zentalis Pharmaceuticals Inc (ZNTL) 最新ニュース
Understanding Zentalis Pharmaceuticals Inc.’s price movement2025 Market Outlook & Smart Swing Trading Alerts - Newser
How to use Fibonacci retracement on Zentalis Pharmaceuticals Inc.2025 Biggest Moves & AI Driven Stock Reports - Newser
Zentalis Pharmaceuticals Inc. stock momentum explainedJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
Aug PreEarnings: Is Zentalis Pharmaceuticals Inc. stock trending bullishJuly 2025 Update & Weekly High Return Opportunities - خودرو بانک
Is Zentalis Pharmaceuticals Inc. stock showing strong momentumFed Meeting & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Will Zentalis Pharmaceuticals Inc. outperform during market ralliesInsider Buying & Momentum Based Trading Signals - خودرو بانک
Will Zentalis Pharmaceuticals Inc. benefit from AI trendsWeekly Trend Summary & Daily Technical Forecast Reports - خودرو بانک
What is the next catalyst for Zentalis Pharmaceuticals Inc.Trade Risk Summary & Verified Momentum Watchlists - خودرو بانک
Published on: 2025-09-05 14:44:43 - Newser
Applying Elliott Wave Theory to Zentalis Pharmaceuticals Inc.2025 Year in Review & Stepwise Trade Signal Guides - Newser
Breakouts Watch: Is Zentalis Pharmaceuticals Inc. stock showing strong momentumQuarterly Profit Report & Accurate Buy Signal Notifications - خودرو بانک
Is a relief rally coming for Zentalis Pharmaceuticals Inc. holdersJuly 2025 Drop Watch & Safe Entry Point Identification - Newser
Zentalis Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Using Ichimoku Cloud for Zentalis Pharmaceuticals Inc. technicalsRate Cut & High Conviction Buy Zone Picks - Newser
Published on: 2025-09-04 22:09:09 - Newser
Why Zentalis Pharmaceuticals Inc. is moving today2025 Big Picture & Fast Gaining Stock Reports - Newser
Using portfolio simulators with Zentalis Pharmaceuticals Inc. includedEarnings Overview Report & Expert Approved Momentum Ideas - Newser
Chart Patterns Forming a Bullish Setup in Zentalis Pharmaceuticals Inc.2025 Trading Volume Trends & Advanced Technical Analysis Signals - beatles.ru
Is Zentalis Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Using data tools to time your Zentalis Pharmaceuticals Inc. exitWeekly Stock Report & High Accuracy Swing Entry Alerts - Newser
Visualizing Zentalis Pharmaceuticals Inc. stock with heatmapsEarnings Growth Report & Safe Capital Growth Plans - Newser
Will Zentalis Pharmaceuticals Inc. outperform the market2025 Market Sentiment & Weekly High Return Opportunities - Newser
Published on: 2025-09-04 07:20:30 - خودرو بانک
Is Zentalis Pharmaceuticals Inc. stock trending bullishMarket Rally & Real-Time Volume Trigger Notifications - خودرو بانک
Using R and stats models for Zentalis Pharmaceuticals Inc. forecastingEarnings Beat & AI Enhanced Trading Alerts - Newser
Zentalis Pharmaceuticals shares fall 1.45% intraday after announcing inducement grants to new employees. - AInvest
Will Zentalis Pharmaceuticals Inc. stock recover after earningsJuly 2025 Breakouts & Risk Managed Investment Strategies - خودرو بانک
Published on: 2025-09-03 05:20:27 - Newser
Will Zentalis Pharmaceuticals Inc. outperform small cap indexesWeekly Profit Analysis & Safe Capital Growth Tips - خودرو بانک
Is Zentalis Pharmaceuticals Inc. impacted by rising ratesCEO Change & Safe Investment Capital Preservation Plans - خودرو بانک
Heatmap analysis for Zentalis Pharmaceuticals Inc. and competitorsBuy Signal & Real-Time Volume Surge Alerts - Newser
Advanced analytics toolkit walkthrough for Zentalis Pharmaceuticals Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - Newser
Can Zentalis Pharmaceuticals Inc. deliver consistent EPS growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - خودرو بانک
Tools to monitor Zentalis Pharmaceuticals Inc. recovery probabilityBuy Signal & Accurate Buy Signal Notifications - Newser
Zentalis Pharmaceuticals announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Zentalis Pharmaceuticals Grants Stock Options to New Employees as Part of Inducement Plan - Quiver Quantitative
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
381,000 Shares: Zentalis Pharmaceuticals Awards Major Stock Options Package to New Executive Hires - Stock Titan
Is Zentalis Pharmaceuticals Inc. forming a bullish divergenceWeekly Trade Report & Free Expert Verified Stock Movement Alerts - خودرو بانک
What are the risks of holding Zentalis Pharmaceuticals Inc.Earnings Beat & Long-Term Growth Plans - خودرو بانک
Can Zentalis Pharmaceuticals Inc. weather a recessionJuly 2025 Levels & Community Driven Trade Alerts - خودرو بانک
Can volume confirm reversal in Zentalis Pharmaceuticals Inc.Market Risk Summary & Proven Capital Preservation Methods - Newser
Long term hold vs stop loss in Zentalis Pharmaceuticals Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Zentalis Pharmaceuticals Inc (ZNTL) 財務データ
収益
当期純利益
現金流量
EPS
Zentalis Pharmaceuticals Inc (ZNTL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Bruns Ingmar | Chief Medical Officer |
Feb 06 '25 |
Buy |
2.28 |
20,000 |
45,656 |
36,629 |
大文字化:
|
ボリューム (24 時間):